1. Home
  2. AROC vs ABVX Comparison

AROC vs ABVX Comparison

Compare AROC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archrock Inc.

AROC

Archrock Inc.

HOLD

Current Price

$36.52

Market Cap

6.5B

Sector

Energy

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$96.91

Market Cap

7.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROC
ABVX
Founded
1990
2013
Country
United States
France
Employees
N/A
69
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.2B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
AROC
ABVX
Price
$36.52
$96.91
Analyst Decision
Strong Buy
Buy
Analyst Count
6
13
Target Price
$40.00
$131.31
AVG Volume (30 Days)
1.6M
2.2M
Earning Date
05-05-2026
03-23-2026
Dividend Yield
2.32%
N/A
EPS Growth
74.29
N/A
EPS
0.41
N/A
Revenue
$1,489,818,000.00
N/A
Revenue This Year
$7.06
$52.14
Revenue Next Year
$5.27
$4,132.27
P/E Ratio
$87.98
N/A
Revenue Growth
28.70
N/A
52 Week Low
$21.17
$5.75
52 Week High
$40.12
$148.83

Technical Indicators

Market Signals
Indicator
AROC
ABVX
Relative Strength Index (RSI) 54.34 41.67
Support Level $34.68 $87.60
Resistance Level $37.33 $131.50
Average True Range (ATR) 1.00 7.71
MACD 0.17 -1.68
Stochastic Oscillator 74.32 41.16

Price Performance

Historical Comparison
AROC
ABVX

About AROC Archrock Inc.

Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Share on Social Networks: